KERNAL BIOLOGICS
Kernal creates mRNA therapies to cure diseases like COVID and cancer. Our mRNA therapies instruct specific cells on how to make their own drugs. Kernal won three awards from Amgen and NASA. With roots at MIT, Harvard and Big Pharma, the team previously built a successful Biotech company and has deep expertise in mRNA space.
KERNAL BIOLOGICS
Industry:
Biotechnology Pharmaceutical Therapeutics
Founded:
2016-08-01
Address:
Cambridge, Massachusetts, United States
Country:
United States
Website Url:
http://www.kernalbio.com
Total Employee:
11+
Status:
Active
Contact:
+118576000762
Total Funding:
25 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Analytics LetsEncrypt Apple Mobile Web Clips Icon Google Tag Manager Content Delivery Network Google Universal Analytics
Similar Organizations
Aclaris Therapeutics
Aclaris Therapeutics is a specialty pharmaceutical company engaged in developing dermatologic therapies.
Apellis Pharmaceuticals
Apellis Pharmaceuticals focuses on developing novel therapeutics and drug delivery technologies to address chronic inflammatory diseases.
Axcella
Axcella is a biotechnology company that treats diseases using endogenous metabolic modulators.
Elicio Therapeutics
Elicio Therapeutics develops an immuno-tumor vaccine to treat cancer.
Jounce Therapeutics
Jounce Therapeutics is developing cancer immune-therapies to harness the immune system to attack cancerous cells and tumors.
Lucy Therapeutics
Lucy Therapeutics is a biotech company providing effective treatments for neurological diseases start with the mitochondria.
Nutcracker Therapeutics
Nutcracker Therapeutics is a biotech company that develops mRNA therapeutics.
Current Advisors List
Board_member
2022-07-07
Current Employees Featured
Yusuf Erkul Co-Founder, CEO @ Kernal Biologics
Co-Founder, CEO
2016-08-01
Helen Liang Investor @ Kernal Biologics
Investor
2020-09-01
Burak Yilmaz Founder @ Kernal Biologics
Founder
2016-09-01
Cafer Ozdemir Director of Convergence ScienceDirector @ Kernal Biologics
Director of Convergence ScienceDirector
2017-09-01
Founder
Investors List
HBM Genomics
HBM Genomics investment in Series A - Kernal Biologics
Amgen Ventures
Amgen Ventures investment in Series A - Kernal Biologics
Civilization Ventures
Civilization Ventures investment in Series A - Kernal Biologics
Hummingbird Ventures
Hummingbird Ventures investment in Series A - Kernal Biologics
Amino Collective
Amino Collective investment in Series A - Kernal Biologics
Julie McDermott
Julie McDermott investment in Seed Round - Kernal Biologics
SAV (Scale Asia Ventures)
SAV (Scale Asia Ventures) investment in Seed Round - Kernal Biologics
ISS National Lab
ISS National Lab investment in Grant - Kernal Biologics
The Boeing Company
The Boeing Company investment in Grant - Kernal Biologics
MassChallenge
MassChallenge investment in Non Equity Assistance - Kernal Biologics
Newest Events participated
Official Site Inspections
http://www.kernalbio.com Semrush global rank: 995.61 K Semrush visits lastest month: 34.66 K
- Host name: ec2-52-25-87-207.us-west-2.compute.amazonaws.com
- IP address: 52.25.87.207
- Location: Boardman United States
- Latitude: 45.8491
- Longitude: -119.7143
- Metro Code: 810
- Timezone: America/Los_Angeles
- Postal: 97818
More informations about "Kernal Biologics"
Kernal Biologics - Crunchbase Company Profile
Organization. Kernal Biologics . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. About. Kernalbio …See details»
About | Kernal Biologics
Hello@kernalbio.com. Synthetic biologists. Immunologists. Data scientists. Together, we’re making selective mRNA drugs to cure serious illnesses. Our goal is to improve patient …See details»
Kernalbio 2025 Company Profile: Valuation, Funding
Kernalbio General Information Description. Developer of mRNA therapies designed to develop curative immunotherapies for cancers and COVID-19. …See details»
Kernal Biologics - LinkedIn
Kernal Biologics Biotechnology Research Cambridge, Massachusetts 3,306 followers KernalBio creates mRNA therapies that instruct specific cells on how to make their own medicineSee details»
Kernal Biologics - Y Combinator
Jul 7, 2022 Kernal is creating mRNA 2.0 therapies that work in specific cells. Founded in 2016 by Yusuf Erkul, Cafer Ozdemir, and Burak YILMAZ, Kernal Biologics has 20 employees based …See details»
Kernal Biologics - Overview, News & Similar companies - ZoomInfo
Kernal Biologics contact info: Phone number: (857) 600-0762 Website: www.kernalbio.com What does Kernal Biologics do? Kernal biologics is a mRNA vaccines and therapeutics research …See details»
Kernal Biologics - Craft
Kernal Biologics has 5 employees at their 1 location and $25.5 m in total funding,. See insights on Kernal Biologics including office locations, competitors, revenue, financials, executives, …See details»
Kernal Biologics - VentureRadar
"Kernal Bio aims to harness the power of our mRNA technology to provide cancer patients with treatments that give them the best chance of beating their disease — while eliminating as …See details»
Kernal Biologics Enters Development Phase Reaching Critical …
In parallel, company expands team with seasoned drug developers and creates a business model to license a portion of its proprietary mRNA technology to global pharmaceutical and biotech …See details»
Kernal Bio - BIO International Convention | BIO
Jun 6, 2023 Kernal Bio is a venture-backed biotech company developing mRNA 2.0 immunotherapies. Kernal Bio mines massive translatome data to discover cell-specific …See details»
Kernal Biologics (USA) Funding: $25M - Medical Startups
Feb 26, 2025 kernal biologics is mRNA vaccine and therapeutics company. It develops onco-selective mRNA...See details»
Kernal Biologics Announces $25M Series A Financing to Advance …
Jul 7, 2022 Appoints Manfred Kraus, Ph.D. as Vice President of Research and Development. CAMBRIDGE, Mass., July 7, 2022 /PRNewswire/ -- Kernal Biologics, Inc. (Kernal Bio) — a …See details»
Kernal Biologics - SymBiosis Capital Management
KernalBio is a developer of mRNA therapies designed to develop curative immunotherapies for cancers and COVID-19. The company’s platform decreases immunogenicity of existing mRNA …See details»
Kernal Biologics to Present at Locust Walk RNA Innovation …
CAMBRIDGE, Mass., May 9, 2023 /PRNewswire/ -- Kernal Bio, a venture-backed biotech company developing mRNA 2.0 immunotherapies, announced today that Yusuf Erkul, M.D., …See details»
Kernal Biologics - VentureRadar
Website: http://www.kernalbio.com. Develops onco-selective mRNA immunotherapy for cancer using AI algorithms to target cancer cells, stimulate immune reactions, and ...See details»
Science | Kernal Biologics
Hello@kernalbio.com. selective translation. mrna 2.0 therapies are intelligently programmed to be active in the target cells, minimizing off-target effects elsewhere. precise targeting. most lnp …See details»
Kernal Biologics Presenting Results at the 9th Annual mRNA
Nov 9, 2021 mRNA 2021 mRNA Health Conference KernalBio mRNA 2.0 NASA ISS Immunogenic Cell Death Cancer therapeutics Oncolytic mRNA anti-PD1 Contact Data …See details»
Solving a molecular mystery for better bioproducts | ORNL
5 days ago Exposure to butanol ultimately triggered changes in the membrane’s organization associated with cell stress and less-efficient fermentation. By identifying for the first time the …See details»
Kernal Biologics Presenting at the 12th mRNA Health Conference
Nov 11, 2024 Kernal Biologics to Present at the 12th International mRNA Health Conference. CAMBRIDGE, Mass., November 11, 2024/ -- Kernal Biologics, Inc. (Kernal Bio) — a …See details»
Pipeline | Kernal Biologics
Hello@kernalbio.com. This is mRNA 2.0. Intelligent therapies right where they’re needed. With the power of mRNA 2.0, our pipeline programs target cancers that have resisted all other …See details»